- Delivering Pan India
Brilinta® (Ticagrelor) Ticagrelor 60 mg and Ticagrelor 90 mg tablets by AstraZeneca. Genuine stock supplied in bulk/wholesale quantities to hospitals and pharmacies across India by A.K. Pharma, a licensed pharmaceutical distributor in Delhi.
| Composition | Ticagrelor 60 mg / Ticagrelor 90 mg |
|---|---|
| Manufacturer | AstraZeneca |
| Country | India |
| Pack size | Ticagrelor 60 mg: 4 x 14 tablets (carton shown); 14-tablet strips listed; Ticagrelor 90 mg: 14 tablets per strip |
| Storage | Store below 30°C. Keep out of reach of children. |
Supplied only against a valid prescription from a registered medical practitioner.
Sourced from authorised channels
Temperature-controlled packing
Hospitals, clinics, pharmacies
Delhi drug licence holder
Brilinta® (Ticagrelor) Ticagrelor 60 mg and Ticagrelor 90 mg Tablets — Ticagrelor 60 mg and 90 mg Tablets: A Sourcing Guide for Hospitals and Pharmacies
Brilinta® is a ticagrelor tablet (P2Y12 platelet inhibitor) marketed in India by AstraZeneca. This single page covers the 60 mg and 90 mg strengths. The decision to prescribe ticagrelor, including patient selection, dose and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.
As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Brilinta® (ticagrelor) Ticagrelor 60 mg and Ticagrelor 90 mg tablets to hospitals and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the cancer medicines category. Supply is in bulk/wholesale quantities only.
Brilinta contains ticagrelor, available as 60 mg and 90 mg film-coated tablets. The 60 mg carton shown is labelled “4 x 14 tablets”, with the 90 mg strength supplied as 14-tablet strips. The carton states that it is to be sold on the prescription of a cardiologist or internal medicine specialist only and not to be stored above 30°C.
How it works, according to the label: The US prescribing information (DailyMed) describes ticagrelor as a P2Y12 platelet inhibitor. Indications and use in India are those printed in the Indian pack insert.
The current US prescribing information for the US prescribing information for Brilinta (DailyMed) lists the following. Indications in India may differ and are defined by the Indian regulator and the Brilinta pack insert.
The pivotal PLATO trial (N Engl J Med 2009) compared ticagrelor with clopidogrel in patients with acute coronary syndromes, and the PEGASUS-TIMI 54 trial (N Engl J Med 2015) studied long-term ticagrelor in patients with prior myocardial infarction. Results and conclusions are those of the trial authors and the prescribing information; A.K. Pharma does not interpret them.
| Strength | Dosage form | Pack size (as shown on the carton) |
|---|---|---|
| Ticagrelor 60 mg | Tablet | 4 x 14 tablets (carton shown); 14-tablet strips listed |
| Ticagrelor 90 mg | Tablet | 14 tablets per strip |
Please confirm the current pack and batch with us before ordering. Dose and regimen must be determined and followed exactly as directed by the treating physician and the approved prescribing information.
Hospitals, cardiology centres and pharmacies in India that need to source Brilinta in bulk quantities from a licensed distributor.
Side effects are listed in the prescribing information and Indian pack insert and are not summarised here. The US label carries a boxed warning on bleeding risk; refer to the label and consult the treating physician.
All use should follow the approved prescribing information and the instructions of the treating physician.
Do not store above 30°C. Keep out of the reach of children, as stated on the carton.
Brilinta is marketed by AstraZeneca. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we source Brilinta through authorised channels and supply it with pack and batch details. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.
Is Brilinta available in India?
A.K. Pharma supplies Brilinta (ticagrelor) Ticagrelor 60 mg and Ticagrelor 90 mg tablets to hospitals and pharmacies in India. Contact us for current availability.
What does Brilinta contain?
Brilinta is a ticagrelor tablet marketed by AstraZeneca in 60 mg and 90 mg strengths. The details of use are those on its label.
Can I order a single pack?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.
How should Brilinta be stored?
The carton states do not store above 30°C.
Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.
How do I request a quote?
Call or WhatsApp us, or use the contact details below.
📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in
Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.
